Born from clinical insight, Thaena^® translates the restorative potential of the human microbiome into safe, shelf-stable innovation. Through years of research and donor screening, the team developed ThaenaBiotic^®, a sterilized, human-derived postbiotic capturing the functional benefits of a healthy microbiome without live organisms. Guided by one belief – humans can help humans heal – Thaena^®, a pioneering a radically human, ecosystem-informed approach to gut resilience and whole-body health. Dr. Sybille served on the board of Thaena since November 2025.